VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
From biologics to gene therapies, learn how Svar Life Science is helping drug developers discover and validate the next wave of modern medicines
Immunology expert, Dr. Anna Majowicz, shares how Spark Therapeutics research is helping tackle immunogenicity challenges in AAV-mediated gene therapy
The context-dependent role of the complement system in cancer has the potential to provide novel prognostic biomarkers to inform treatment decisions for cancer patients
Deepen your understanding of cell-based assays and the process of developing robust cell-based assays for GMP QC testing in modern drug development
Explore the importance of robust and reliable cell-based assays in the development of therapeutic bispecific antibodies in immuno-oncology
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines
Explore the role of the complement system in infectious disease and discover the immunoassays that drive research, diagnostics, and therapeutic monitoring
